Skip to main content

Table 4 Multivariate Analysis of Prognostic Factors for OS and PFS in 73 LAPC patients

From: Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic Cancer treated with stereotactic body radiation therapy

Factors

OS

 

PFS

B Value

Wald Value

P Value

HR (95%CI)

B Value

Wald Value

P Value

HR(95%CI)

Radiotherapy dose

−0.735

8.090

0.004

0.480(0.289~0.796)

−0.525

4.521

0.033

0.591(0.364~0.960

Chemotherapy

−0.752

6.698

0.010

0.471(0.267~0.833)

− 0.559

4.198

0.040

0.572(0.335~0.976)

TLG

0.763

8.704

0.003

2.145(1.292~3.560)

0.836

10.938

0.001

2.307(1.406~3.787)

  1. LAPC locally advanced pancreatic cancer; OS overall survival; PFS progression-free survival; TLG total lesion glycolysis
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us